IDERA PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Collaboration Agreements (6 contracts)
- Development Agreements (1)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Voting Agreements (3)
- Form of Stockholder Voting Agreement, dated as of July 10, 2023, entered into by and between Aceragen, Inc. and each of Atul Chopra, John Taylor, Dan Salain and Andrew Jordan (Filed With SEC on July 11, 2023)
- Therapeutic Development Award Agreement, by and between Arrevus, Inc. and Cystic Fibrosis Foundation, dated December 13, 2021 (Filed With SEC on November 14, 2022)
- Sales Distribution and PRV Agreement, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P., dated October 25, 2021 (Filed With SEC on November 14, 2022)
- Voting Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
- Voting Agreement, dated as of December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain investors named therein (Filed With SEC on March 12, 2020)
- Clinical Trial Collaboration and Supply Agreement, effective August 27, 2019, by and between AbbVie Inc. and Idera Pharmaceuticals, Inc (Filed With SEC on November 6, 2019)
- Clinical Trial Collaboration and Supply Agreement, by and between Idera Pharmaceuticals, Inc. and Bristol-Myers Squibb Company, dated March 11, 2019 (Filed With SEC on May 2, 2019)
- Clinical Trial Collaboration and Supply Agreement, by and between Idera Pharmaceuticals, Inc. and Bristol-Myers Squibb Company, dated May 18, 2018 (Filed With SEC on August 2, 2018)
- INDEMNIFICATION AGREEMENT (Filed With SEC on May 4, 2017)
- IDERA PHARMACEUTICALS, INC. $10,000,000 SALES AGREEMENT (Filed With SEC on April 13, 2012)
- Ex-10.1 Exclusive License and Research Collaboration Agreement, dated December 8, 2006 (Filed With SEC on March 6, 2007)
- EX-10.1 Research Collaboration and Option Agreement (Filed With SEC on August 9, 2005)
- EX-10.42 AMEND 1 TO COLLABORATION AGREEMENT (Filed With SEC on March 31, 2003)
